ER+/HER2- BREAST CANCER

Clinical trials for ER+/HER2- BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new ER+/HER2- BREAST CANCER trials appear

Sign up with your email to follow new studies for ER+/HER2- BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 2

Viagra tested as surprising new treatment for cancer fatigue and brain fog

Symptom relief Not yet recruiting

This study tests whether a daily 50mg dose of sildenafil (Viagra) can prevent or reduce the fatigue and cognitive problems (brain fog) that often come with cancer treatment. The trial will enroll 30 women with ER+/HER2- breast cancer, aged 30-50, and track their symptoms using qu…

Matched conditions: ER+/HER2- BREAST CANCER

Phase: PHASE2, PHASE3 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Symptom relief

Last updated Jun 27, 2026 12:32 UTC

ER+/HER2- BREAST CANCER

Get alerted when new ER+/HER2- BREAST CANCER trials appear

Viagra tested as surprising new treatment for cancer fatigue and brain fog